Aspen Wealth Strategies’s AbbVie ABBV Stock Holding History

Aspen Wealth Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.13M	Sell	9,812 -54	-0.5%	-$12K	1.14%	20
2025 Q4	$2.25M	Sell	9,866 -28	-0.3%	-$6.38K	1.23%	20
2025 Q3	$2.29M	Buy	9,894 +99	+1%	+$20.2K	1.27%	16
2025 Q2	$1.82M	Sell	9,795 -382	-4%	-$71K	1.1%	18
2025 Q1	$2.13M	Sell	10,177 -129	-1%	-$25.1K	1.4%	15
2024 Q4	$1.83M	Buy	10,306 +277	+3%	+$50.9K	1.17%	15
2024 Q3	$1.98M	Sell	10,029 -615	-6%	-$115K	1.28%	12
2024 Q2	$1.87M	Sell	10,644 -100	-0.9%	-$16.6K	1.3%	12
2024 Q1	$1.96M	Sell	10,744 -719	-6%	-$124K	1.35%	13
2023 Q4	$1.78M	Buy	11,463 +61	+0.5%	+$8.89K	1.29%	15
2023 Q3	$1.7M	Buy	11,402 +164	+1%	+$24.1K	1.33%	14
2023 Q2	$1.51M	Sell	11,238 -556	-5%	-$81.5K	1.15%	13
2023 Q1	$1.88M	Sell	11,794 -205	-2%	-$31.3K	1.46%	13
2022 Q4	$1.94M	Buy	+11,999	New	+$1.84M	1.55%	12

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aspen Wealth Strategies's ABBV Position: Q1 2026 in Review

Aspen Wealth Strategies reduced its AbbVie (ABBV) stake by 0.55% in Q1 2026, selling an estimated $12K and leaving 9,812 shares worth $2.13M. The position accounts for 1.14% of the portfolio, ranked #20.

Aspen Wealth Strategies first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.29M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Aspen Wealth Strategies held 9,812 shares of AbbVie worth $2.13M as of Q1 2026.
Aspen Wealth Strategies sold 54 AbbVie shares in Q1 2026, an estimated $12K.
AbbVie made up 1.14% of Aspen Wealth Strategies's portfolio in Q1 2026, its #20 holding.
Aspen Wealth Strategies first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Aspen Wealth Strategies's AbbVie position peaked at $2.29M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Aspen Wealth Strategies's 13F filing for Q1 2026, filed 8 May 2026.